DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Dianthus Therapeutics, Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$74.54+2.45 (+3.40%)
Close on Oct 19, 2026
- Market cap
- $4.18B
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Charting library not installed
Copy the licensed TradingView charting_library folder to apps/web/public/charting_library/, or set TV_LIBRARY_PATH, then reload. Setup steps are in docs/ADVANCED-CHARTS.md.